Exhibit 10.2



 






Exhibit 10.2




AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT




     THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between
Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Edward J. Borkowski (the
“Executive”), is made as of December 2, 2004.



     WHEREAS, the Company and the Executive are parties to that certain Transition and Succession
Agreement dated as December 15, 2003 (the “Agreement”); and



     WHEREAS, the Company and the Executive wish to amend the Agreement, as set forth below;



     NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:




	1.  	The last sentence of Section 3(a) of the Agreement is hereby amended and restated in its
entirety to read as follows:






In addition, for three years after the date the Executive’s employment
terminates, or such longer period as may be provided by the terms of the appropriate
plan, program, practice or policy, the Company shall continue to provide benefits to
the Executive and/or the Executive’s dependents at least equal to those that were
provided to them (taking into account any required employee contributions, co-payments
and similar costs imposed on the Executive and the Executive’s dependents and the tax
treatment of participation in the plans, programs, practices and policies by the
Executive and the Executive’s dependents) by or on behalf of the Company and or the
Affiliated Companies in accordance with the benefit plans, programs, practices and
policies (including those provided under the Employment Agreement) in effect
immediately prior to a Change of Control or, if more favorable to the Executive, as in
effect any time thereafter with respect to other peer executives of the Company and the
Affiliated Companies and their dependents; provided, however, that, if the Executive
becomes reemployed with another employer and is eligible to receive such benefits under
another employer provided plan, program, practice or policy, the medical and other
welfare benefits described herein shall be secondary to those provided under such other
plan, program, practice or policy during such applicable period of eligibility.




	2.  	Section 3(b) of the Agreement is hereby amended and restated in its entirety to read as
follows:






(b)(1) Whether or not the Executive becomes entitled to any payments
hereunder, if any of the payments or benefits received or to be received by the
Executive (including any payment or benefits received in connection with a



 









 






Change of Control or the Executive’s termination of employment, whether pursuant to
the terms of this Agreement or any other plan, arrangement or agreement) (all such
payments and benefits, excluding the Gross-Up Payment, being hereinafter referred to as
the “Total Payments”) will be subject to the excise tax (“the Excise Tax”) imposed
under Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), the
Company shall pay to the Executive an additional amount (the “Gross-Up Payment”) such
that the net amount retained by the Executive, after deduction of any Excise Tax on the
Total Payments and any federal, state and local income and employment taxes and Excise
Tax upon the Gross-Up Payment, and after taking into account the phase out of itemized
deductions and personal exemptions attributable to the Gross-Up Payment, shall be equal
to the Total Payments.




(b)(2) For purposes of determining whether any of the Total Payments will be
subject to the Excise Tax and the amount of such Excise Tax, (i) all of the Total
Payments shall be treated as “parachute payments” (within the meaning of Section
280G(b)(2) of the Code) unless, in the opinion of tax counsel (“Tax Counsel”)
reasonably acceptable to the Executive and selected by the accounting firm which was,
immediately prior to the Change of Control, the Company’s independent auditor (the
“Auditor”), such payments or benefits (in whole or in part) do not constitute parachute
payments, including by reason of Section 280G(b)(4)(A) of the Code, (ii) all “excess
parachute payments” within the meaning of Section 280G(b)(l) of the Code shall be
treated as subject to the Excise Tax unless, in the opinion of Tax Counsel, such excess
parachute payments (in whole or in part) represent reasonable compensation for services
actually rendered (within the meaning of Section 280G(b)(4)(B) of the Code) in excess
of the Base Amount (as defined in Section 280G(b)(3) of the Code) allocable to such
reasonable compensation, or are otherwise not subject to the Excise Tax, and (iii) the
value of any noncash benefits or any deferred payment or benefit shall be determined by
the Auditor in accordance with the principles of Sections 280G(d)(3) and (4) of the
Code. For purposes of determining the amount of the Gross-Up Payment, the Executive
shall be deemed to pay federal income tax at the highest marginal rate of federal
income taxation in the calendar year in which the Gross-Up Payment is to be made and
state and local income taxes at the highest marginal rate of taxation in the state and
locality of the Executive’s residence on the Date of Termination (or if there is no
Date of Termination, then the date on which the Gross-Up Payment is calculated for
purposes of this Section 3(b)), net of the maximum reduction in federal income taxes
which could be obtained from deduction of such state and local taxes.




(b)(3) In the event that the Excise Tax is finally determined to be less than the
amount taken into account hereunder in calculating the Gross-Up Payment, the Executive
shall repay to the Company, within five (5) business days following the time that the
amount of such reduction in the Excise Tax is finally determined, the portion of the
Gross-Up Payment attributable to such



2









 






reduction (plus that portion of the Gross-Up Payment attributable to the Excise Tax
and federal, state and local income and employment taxes imposed on the Gross-Up
Payment being repaid by the Executive), to the extent that such repayment results in a
reduction in the Excise Tax and a dollar-for-dollar reduction in the Executive’s
taxable income and wages for purposes of federal, state and local income and employment
taxes, plus interest on the amount of such repayment at 120% of the rate provided in
Section 1274(b)(2)(B) of the Code. In the event that the Excise Tax is determined to
exceed the amount taken into account hereunder in calculating the Gross-Up Payment
(including by reason of any payment the existence or amount of which cannot be
determined at the time of the Gross-Up Payment), the Company shall make an additional
Gross-Up Payment in respect of such excess (plus any interest, penalties or additions
payable by the Executive with respect to such excess) within five (5) business days
following the time that the amount of such excess is finally determined. The Executive
and the Company shall each reasonably cooperate with the other in connection with any
administrative or judicial proceedings concerning the existence or amount of liability
for Excise Tax with respect to the Total Payments.




	3.  	This Amendment shall be governed by, interpreted under and construed in accordance with the
laws of the Commonwealth of Pennsylvania.
	 
	4.  	This Amendment may be executed in counterparts, each of which shall be an original and all of
which shall constitute the same document.
	 
	5.  	Except as modified by this Amendment, the Agreement is hereby confirmed in all respects.





     IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the day and
year first above written.



	 	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	 	 	     
	 	 	MYLAN LABORATORIES INC.	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	/s/ Robert J. Coury	 	 
	 	 	 	 	 
	 	 	By: Robert J. Coury	 	 
	 	 	Title: Vice Chairman and	 	 
	 	 	 	 	 	 	Chief Executive Officer
	 
	 	 	 	 	 	 	 	 
	 	 	EXECUTIVE	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	/s/ Edward J. Borkowski	 	 
	 	 	 	 	 
	 	 	Edward J. Borkowski	 	 






3